Marker Therapeutics, Inc. (MRKR)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2024-12-23NEA Partners 16, L.P.ten percent ownerP554,2503.2$1,773,600
2024-12-23ELMS STEVEdirectorP11,0853.2$35,472

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings